New York State Common Retirement Fund An2 Therapeutics, Inc. Transaction History

New York State Common Retirement Fund

  • $76.2 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 07, 2023
SELL
$5.06 - $9.91 $29,236 - $57,259
-5,778 Reduced 98.28%
101 $1,000
Q1 2023

May 02, 2023
BUY
$7.94 - $15.6 $428 - $842
54 Added 0.93%
5,879 $58,000
Q3 2022

Nov 08, 2022
SELL
$7.61 - $22.29 $42,425 - $124,266
-5,575 Reduced 48.9%
5,825 $101,000
Q2 2022

Aug 04, 2022
BUY
$7.7 - $18.82 $87,780 - $214,548
11,400 New
11,400 $88,000

Others Institutions Holding ANTX

# of Institutions
48
Shares Held
19.4M
Call Options Held
0
Put Options Held
0
View Full List

About AN2 Therapeutics, Inc.

ANTX Quotes by TradingView
  • Ticker ANTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 19,402,700
  • Market Cap $20.2M
  • Description
  • AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menl...
More about ANTX
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email